Back to VANGUARD GROUP INC VANGUARD GROUP INC

RARERARE
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in Ultragenyx Pharmaceutical, Inc.

VANGUARD GROUP INC holds 10.3M shares of RARE (Ultragenyx Pharmaceutical, Inc.), worth $236.1M as of 2025-Q4. The position was increased (+1.3% shares). RARE represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$236.1M

Current Shares

10.3M

Total Value Change

-$316.4M

Total Shares Change

+318,342

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
10.3M
+1.3%
$236.1M0.0%$22.78
31
2025-Q3
Decreased
10.1M
-0.8%
$304.8M0.0%$30.36
0
2025-Q2
Increased
10.2M
+2.2%
$371.4M0.0%$36.52
32
2025-Q1
Decreased
10M
-0.4%
$362M0.0%$37.82
0
2024-Q4
Increased
10M
+0.9%
$422.2M0.0%$42.27
31
2024-Q3
New
9.9M
-
$552.5M0.0%$54.43
43

Other major holders of RARE: Capital Research Global Investors, BNP PARIBAS FINANCIAL MARKETS, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used